SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,671 | +28.0% | 583 | +21.0% | 0.00% | +100.0% |
Q2 2023 | $55,199 | -9.2% | 482 | +9.3% | 0.00% | -50.0% |
Q1 2023 | $60,783 | +22.2% | 441 | +14.8% | 0.00% | +100.0% |
Q4 2022 | $49,759 | +18.5% | 384 | +2.1% | 0.00% | 0.0% |
Q3 2022 | $42,000 | +50.0% | 376 | +1.9% | 0.00% | 0.0% |
Q2 2022 | $28,000 | -3.4% | 369 | -1.1% | 0.00% | 0.0% |
Q1 2022 | $29,000 | -52.5% | 373 | -45.2% | 0.00% | -50.0% |
Q4 2021 | $61,000 | -11.6% | 681 | -8.6% | 0.00% | 0.0% |
Q3 2021 | $69,000 | +32.7% | 745 | +12.4% | 0.00% | 0.0% |
Q2 2021 | $52,000 | +147.6% | 663 | +136.8% | 0.00% | +100.0% |
Q1 2021 | $21,000 | +200.0% | 280 | +551.2% | 0.00% | – |
Q4 2020 | $7,000 | +40.0% | 43 | +10.3% | 0.00% | – |
Q3 2020 | $5,000 | +25.0% | 39 | +39.3% | 0.00% | – |
Q2 2020 | $4,000 | +300.0% | 28 | +250.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 8 | +14.3% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 7 | +600.0% | 0.00% | – |
Q2 2019 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |